Podcasts about eloctate

This month on The BloodStream Podcast, community member Kevin Krivosik shares his journey toward independence, Camp Casey Founder Molly Reeser joins us to share the camp’s mission and her inspiration for starting it, and we take a look a recent Forbes Magazine piece highlighting one of the many challenges in mental health treatment. And using a combination of written statements, audio recordings, and his own original writing, we say goodbye to community leader Barry Haarde. All that and more on Episode 22 on The BloodStream Podcast!   Exclusive Sponsor: Shire   Hemophilia and Young Adulthood, a new podcast series: BloodLinePod.com   Bleeding Disorders Awareness Month: RedTieCampagin.org   Like Segment: Psychiatrist Shortage Escalates As U.S. Mental Health Needs Grow   Share Segment: Kevin Krivosik - “Third Time’s a Charm” Comment Segment/Remembering Barry Haarde: Remembering the Rain: Barry Haarde   Interview Segment: Camp Casey Founder Molly Reeser   Community News in 60 Seconds: Patient Advocacy Groups Worldwide Plan Events Marking Rare Disease Day (Feb 28) The National Heart, Lung, and Blood Institute to host workshop on Factor VIII Inhibitors May 15-16 in Bethesda, Md.   The UK’s First Genome-Editing Study Is Underway with Phase ½ on SB-FIX   Hemlibra receives approval in Europe   Adynovate receive approval in South Korea   Eloctate show “promise” for use in immune tolerance induction (ITI) therapy.   BloodFeed: https://www.bloodfeed.com Connect with BloodStream: Email mailbag@bloodstreammedia.com Find all of our bleeding disorders podcasts on BloodStreamMedia.com BloodStream Facebook Page BloodStream Twitter Account Subscribe to BloodStream: iTunes: http://bit.ly/bloodstreamitunes Stitcher: http://bit.ly/bloodstreamstitcher LibSyn: http://bit.ly/bloodstreamlibsyn SoundCloud: http://bit.ly/bloodstreamSC TuneIn: http://bit.ly/bloodstreamtunein Google Play: http://bit.ly/bloodstreamPlay Spotify: http://spoti.fi/2nNPhui

Today in FirstWord:

Today in FirstWord: